stars 1 stars 2 stars 3

As the home of EastCann, FOUR54, IRIS Labs, Origin Coast, and MSIKU, AMI leverages a diverse portfolio of cultivars and industry-leading cultivation practices to deliver bold, exciting cannabis experiences. Each cultivar at AMI is grown in a tightly controlled environment, guided by rigorous quality assurance protocols. Every batch is third-party lab tested by Health Canada–approved laboratories for cannabinoid potency (THC, CBD), terpene profiles, and the absence of microbial or chemical contaminants. Each cultivar at AMI is grown in a tightly controlled environment, guided by rigorous quality assurance protocols. Every batch is third-party lab tested by Health Canada–approved laboratories for cannabinoid potency (THC, CBD), terpene profiles, and the absence of microbial or chemical contaminants.

Website https://atlanticann.com/
Employees 25 (14 on RocketReach)
Founded 2014
Industry Pharmaceutical Manufacturing

AMI Questions

Michael Coggins is the Shareholder and Partner of AMI.

14 people are employed at AMI.

AMI is based in Lower Sackville, Nova Scotia.

Top AMI Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users